NGS-based RNA-seq Market is estimated to grow at a CAGR of 19.7% during 2018 to 2022 | Vital Players are Roche Holding AG, QIAGEN N. V., Thermo Fisher Scientific Inc., PerkinElmer, Inc., BGI, Oxford Nanopore Technologies, Ltd.

NGS-based RNA-seq Market Size and Growth Rate:
NGS-based RNA-seq Market was valued at USD 0.89 billion in 2017 and projected to reach USD 2 billion by 2022 growing at a CAGR of 19.7% during the forecast period 2018 to 2022.

NGS-based RNA-seq Market Overview:
With the introduction of next-generation sequencing technology, demand has increased dramatically worldwide. It is widely used in conventional and non-conventional applications to obtain advanced and complete information at the genomic level. The growing demand for advanced diagnostics based on sequencing has created the demand for new security technologies as a result, devices such as high-performance sequencers and robust portable units have increased significantly.

Browse details of 145 number of pages research report developed on NGS-based RNA-seq Market @ https://www.researchcosmos.com/reports/global-ngs-based-rna-seq-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/6815340

NGS-based RNA-seq Market Growth Drivers and Restraints:
The demand for RNA-seq based on NGS is increasing due to a variety of factors, including technological advances in RNA-based products, the benefits of RNA technology over the microarray, the rapid growth of research as expected, the growing number of grants and a significant demand for precision medicine. The increasing technological advances in the biotechnology also drive demand in the global NGS-based RNA-seq market around the world.

Geographic Insights of NGS-based RNA-seq Market:
North America is expected to dominate the market due to the presence of key market players and a well-established computer network. In addition, favorable regulatory policies for the use and approval of genetic tests, the growing number of genomic tests approved by the FDA in the USA has increased the demand in this market even more.

On the other hand, Asia Pacific should create lucrative opportunities for this market. Increasing government initiatives to provide better public health facilities and investing huge amounts of money in advanced diagnostic approaches are the key factors driving the demand for RNA-seq based on NGS. Around the world, key players are also interested in investing in emerging economies in the Asia-Pacific region. By investing huge sums in this market in the region, they will position themselves better and can develop their activities.

Ask Free Sample of the report @ https://www.researchcosmos.com/request/global-ngs-based-rna-seq-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/6815340

Key Market Players of NGS-based RNA-seq Market:
The competition among the key players in the market is likely to increase in the coming years with an aim to get a stronger hold in the market. the report focuses on companies like Illumina, Inc., Roche Holding AG, QIAGEN N. V., Thermo Fisher Scientific Inc., PerkinElmer, Inc., BGI, Oxford Nanopore Technologies, Ltd., Pacific Biosciences of California, Inc., Agilent Technologies, Inc., Macrogen, Inc., and GATC Biotech AG players that are functional in the global NGS-based RNA-seq market.

NGS-based RNA-seq Market Key Segmentation:

By Technology:
• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Single-Molecule Real-Time Sequencing
• Nanopore Sequencing

By Product & Service:
• Sample Preparation
• Sequencing Platforms and Consumables
• Sequencing Services
• Data Analysis, Storage, and Management

By Application:
• Expression Profiling Analysis
• Small RNA Sequencing
• De Novo Transcriptome Assembly
• Variant Calling and Transcriptome Epigenetics

By End User:
• Research Centers and Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies

By Region:
• North America
• South America
• Europe
• Asia Pacific
• Middle East and Africa

For any queries, inquire more @ https://www.researchcosmos.com/inquire/global-ngs-based-rna-seq-market-analysis-and-forecast-to-2022-growth-opportunity-assessment/6815340

About Us:
Research Cosmos is a provider of standard and customized market research, business intelligence and consulting services across more than 100 domains in different industries of the world. We host the trending market reports of the world’s top-notch publishing companies, offering services to a wide range of customers from students to fortune 500 companies and discloses the hidden opportunities in every leading industry of the world.

Contact:
Kevin Stewart
Global Sales Manager
Research Cosmos
www.researchcosmos.com
Blog: https://acutemarketinsights.com
Blog: https://marketreportsweb.com/

This release was published on openPR.